mylife Loop for more freedom in all life phases
Ypsomed AG |
Wednesday
4 October 2023 18:35 – 18:45 CEST Virtual
Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?
PeerVoice // supported by an educational grant from Lilly |
Tuesday
Chair: Paolo Sbraccia (ITA) 07:45 – 07:48 Welcome and Introduction Paolo Sbraccia (ITA) 07:48 – 08:03 Reframing Obesity as a Chronic Disease Carel le Roux (IRL) 08:03 – 08:18 Painting a Clear Picture of Obesity Through Effective Screening, Evaluation, and Diagnosis Naveed Sattar (UK) 08:18 – 08:33 Expert Perspectives on the Practicalities of Obesity Care […]
Establishing the role of the MiniMed™ 780G system in the treatment of type 1 diabetes: world-wide experience
Medtronic International Trading Sàrl |
Tuesday
Chairs: Olga Kordonouri (GER), Ohad Cohen (ISR) 07:45 – 07:51 Moving towards new glycemic treatment goals (TITR) for young people with type 1 diabetes: insights from the SWEET registry Olga Kordonouri (GER) 07:51 – 08:01 Insights from real-world evidence in glycemic metrics: something new, something old Ohad Cohen (ISR) 08:01 – 08:11 Expanding the access […]
Addressing the utmost challenge for women living with T1D: insights from the AiDAPT AID pregnancy trial
Ypsomed AG |
Tuesday
Chair: Helen Murphy (UK) 07:45 – 08:05 Automating insulin delivery to optimize pregnancy outcomes: the AiDAPT trial Helen Murphy (UK) 08:05 – 08:20 Practical implications for clinical practice: the way forward Tara Lee (UK) 08:20 – 08:35 Widening access to advanced technolgies: the UK experience Eleanor Scott (UK) 08:35 – 08:45 Questions & Answers All […]
Triple Action in Type 2 Diabetes Management: Canagliflozin in Focus
Menarini Group |
Tuesday
Chair: Stefano Del Prato (ITA) 18:30 – 18:32 General introduction: from active to proactive diabetes management Stefano Del Prato (ITA) 18:32 – 18:39 Prioritize early glycaemic control John Wilding (UK) 18:39 – 18:46 Kidney Protection: CREDENCE study under the magnifying glass David Wheeler (UK) 18:46 – 18:53 Do not forget the heart: Diabetes and Cardiovascular […]
Busting Myths of Glucose Sensing Technology and Rethinking the Treatment Limits
Abbott |
Tuesday
Chair: Stephen Dixon (UK) 18:30 – 18:35 Welcome and introduction Stephen Dixon (UK) 18:35 – 18:50 Myth #1: Glucose sensing technology is too complex for my practice and patients! Boris Klanger (SWE)Markus Menzen (GER) 18:50 – 19:05 Myth #2: Only patients on intensive insulin treatment benefit from glucose sensing technology! Ramzi Ajjan (UK)Maddalena Lettino (ITA) […]
Metformin – for newbies and experts
Merck Healthcare KGaA |
Tuesday
Chair: Clifford J. Bailey (UK) 18:30 – 18:33 Introduction Clifford J. Bailey (UK) 18:33 – 18:50 Why is metformin good at its job Clifford J. Bailey (UK) 18:50 – 19:07 Make the best of metformin Nemencio A. Nicodemus (PHL) 19:07 – 19:24 Metformin in the long run José Silva-Nunes (PRT) 19:24 – 19:30 Questions and […]
Ertugliflozin in the Holistic-Person Centered Approach to T2DM Management
MSD |
Tuesday
Co-Chairs: Mariana Monteiro (PRT), Dirk Müller-Wieland (GER) 18:30 – 18:35 Opening Remarks Co-Chairs 18:35 – 18:45 Ertugliflozin & Glycemic Management in the Holistic-Person Centered Approach to T2DM Management Sam Dagogo-Jack (USA) 18:45 – 18:55 Ertugliflozin & Weight Management in the Holistic-Person Centered Approach to T2DM Management Linong Ji (CHN) 18:55 – 19:05 Ertugliflozin & Cardiovascular […]
Delaying Progression of Type 1 Diabetes: An Emerging Reality?
Medscape Education Global // supported by an independent educational grant from Sanofi |
Tuesday
Chair: Jay Skyler (USA) 18:30 – 18:39 Screening for Type 1 Diabetes: Who is at Risk? Colin Dayan (UK) 18:39 – 18:48 Delaying the Progression of Type 1 Diabetes: Emerging Treatment Options Jay Skyler (USA) 18:48 – 18:57 Implementing Best Practice for T1D Management with Patients and Families Rachel Besser (UK) 18:57 – 19:00 Conclusion […]
A multidisciplinary approach to T2D, obesity, and CVD: current evidence and a look to the future
Novo Nordisk A/S |
Tuesday
Chair: Ildiko Lingvay (USA) 19:00 – 19:10 Welcome and introductions: CV risk in people with T2D and/or obesity Ildiko Lingvay (USA) 19:10 – 19:28 The effect of GLP-1RAs on CVD and cardio-renal-metabolic risk factors in patients with obesity and/or T2D Subodh Verma (CAN) 19:28 – 19:40 GLP-1RAs: What does the future hold? Nikolaus Marx (GER) […]
